+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Glucose Monitoring Devices: Global Strategic Business Report

  • PDF Icon

    Report

  • 268 Pages
  • March 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 338886

Global Glucose Monitoring Devices Market to Reach $19.2 Billion by 2030

The global market for Glucose Monitoring Devices estimated at US$13.1 Billion in the year 2022, is projected to reach a revised size of US$19.2 Billion by 2030, growing at a CAGR of 4.8% over the analysis period 2022-2030. Self-Monitoring Devices, one of the segments analyzed in the report, is projected to record 4% CAGR and reach US$11.3 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Continuous Blood Glucose Monitoring Devices segment is readjusted to a revised 6.2% CAGR for the next 8-year period.

The U.S. Market is Estimated at $3.6 Billion, While China is Forecast to Grow at 8% CAGR

The Glucose Monitoring Devices market in the U.S. is estimated at US$3.6 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$4.1 Billion by the year 2030 trailing a CAGR of 8% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 1.6% and 5.3% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 2.6% CAGR.

Select Competitors (Total 32 Featured) -

  • Abbott Diabetes Care, Inc.
  • ACON Laboratories, Inc.
  • AgaMatrix, Inc.
  • Alive Technologies Pty. Ltd.
  • ARKRAY, Inc.
  • Ascensia Diabetes Care Holdings AG
  • B. Braun Melsungen AG
  • Beurer GmbH
  • Dexcom, Inc.
  • GlySens Inc.
  • LifeScan, Inc.
  • Medtronic plc
  • Nova Biomedical Corporation
  • Omron Healthcare Co., Ltd.
  • Roche Diagnostics
  • Senseonics Holdings, Inc.
  • Terumo Corporation
  • Trividia Health, Inc.
  • Ypsomed Holding AG

What's New?

  • Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
  • Global competitiveness and key competitor percentage market shares
  • Market presence across multiple geographies - Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to digital archives and Research Platform
  • Complimentary updates for one year

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Glucose Monitoring Devices: Enabling Easier and Efficient Monitoring of the Global Diabetes Epidemic
  • Growth Drivers in a Nutshell
  • Recent Market Activity
  • Glucose Monitoring Undergoes Notable Transformation over the Years: An Evolutionary Scan
  • Evolution of Diabetes Testing over the Years with Key Features in Each Period
  • Diabetes Incidence Reaching Epidemic Proportions Worldwide: Foundation for Market Growth
  • Diabetes: One of the Leading Causes of Death Globally
  • Diabetes Incidence and Prevalence by Region/Country
  • Global Market Outlook
  • Developed Countries are Dominant Markets, while Developing Countries Spearhead Market Growth
  • Glucose Monitoring Devices - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Growing Popularity of Smart, Compact, Digital, Ergonomic, and Wireless Glucose Monitors Drive Healthy Market Growth
  • Select Disruptive Glucose Monitors Promising Reduced Pain, Lesser Data Load, and Zero Worries
  • Innovative Smart Glucometers for Sugar Monitoring
  • Need for Real-Time Glucose Sensing and Monitoring Drive Strong Demand for Minimally-Invasive CGM Devices
  • Myriad Benefits of CGMs
  • CGM Market Gradually Breaks through Barriers to Adoption
  • Intensive Care Units: A Highly Promising Market for CGMs
  • Key Challenges Hampering Widespread Adoption of CGM Systems
  • Despite Competition from CGM Systems, SGM Devices Continue to Dominate Sales
  • Blood Glucose Test Strips: The Largest Segment
  • Cost: The Ultimate Factor Favoring Growth in Demand for Blood Glucose Monitoring Systems
  • Self-Monitoring/Household Blood Glucose:Sustaining Growth in Demand
  • Key Trends in the Glucose Meter/Monitoring Systems
  • Smartphone Penetration Favors SMBG Market
  • Barriers to Adoption of New Technology in BGM Products
  • Accuracy Issues Plague Blood Glucose Meters Market
  • Advancements in Glucose Monitoring Devices Offers a New Ray of Hope
  • Undiagnosed Diabetes: A Major Healthcare Challenge Offering Huge Untapped Potential
  • Undiagnosed Diabetics: More Prone to Cardiovascular Diseases
  • Increased Vulnerability of Diabetics to Various Health Complications Drives the Need for Timely Glucose Monitoring
  • Non-Insulin-Dependent Diabetes Mellitus (NIDDM) Lead to Cardiovascular Complications
  • Higher Risk of Diabetes in the Fast Expanding Aging Population Benefit Market Expansion
  • Demographic Statistics of the Global Aging Populace: Unfurling the Market Potential
  • Increasing Healthcare Expenditure Boosts Demand for SGM and CGM Devices
  • Increasing Obesity Levels Underpins Market Growth
  • K’Track: Discreet and Painless Glucose- Monitoring Wearable
  • The Sugar iQ App Provide Predictive Diabetes Care
  • DIABNEXT® CLIPSULIN®: World’s First A.I Tool for Diabetes
  • e-mosquito CGM Device
  • FreeStyle Libre Flash Glucose Monitoring System
  • MyDario Mobile Data Management Platform
  • The New Handheld RL-BGM Device
  • TOUCH TG
  • Pocket-Sized Gadgets
  • Digital Contact Lenses
  • Gamification
  • Leveraging Big Data
  • Digital Tattoos
  • OneTouch® Verio Flex® Monitoring System
  • Artificial Pancreas System (APS): The Next Big Thing in Glucose Monitoring
  • The First-of-its-Kind Artificial Pancreas by Medtronic
  • Non-invasive, Acetone Detecting Breathalyzer for Glucose Testing
  • Nanotechnology-based Breathalyzer for Non-Invasive Glucose Monitoring
  • EMG 1000: Needle-free Device for Glucose Monitoring
  • Glucase: Smartphone Case with Glucose Testing Kit
  • Painless Diabetes Monitoring Using NFC Technology
  • GlucoSense: Laser Device for Non-invasive Monitoring of Glucose Levels
  • ClearPath DS-120: Enabling Early Detection of Diabetes & Prediabetes
  • NoStrip™ Technology: Eliminating Need for Individual Test Strips
  • Other Innovative and Advanced Glucose Monitoring Systems
  • Notable Early-stage Investigative Glucose Monitoring Devices
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 2: World Historic Review for Glucose Monitoring Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 3: World 18-Year Perspective for Glucose Monitoring Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2023 & 2030
  • Table 4: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 5: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 6: World 18-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
  • Table 7: World Recent Past, Current & Future Analysis for Home Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 8: World Historic Review for Home Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 9: World 18-Year Perspective for Home Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
  • Table 10: World Recent Past, Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 11: World Historic Review for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 12: World 18-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
  • Table 13: World Recent Past, Current & Future Analysis for Self-Monitoring Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 14: World Historic Review for Self-Monitoring Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 15: World 18-Year Perspective for Self-Monitoring Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
  • Table 16: World Recent Past, Current & Future Analysis for Continuous Blood Glucose Monitoring Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 17: World Historic Review for Continuous Blood Glucose Monitoring Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 18: World 18-Year Perspective for Continuous Blood Glucose Monitoring Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
  • Table 19: World Glucose Monitoring Devices Market Analysis of Annual Sales in US$ Million for Years 2012 through 2030
III. MARKET ANALYSIS
UNITED STATES
  • Glucose Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
CANADA
JAPAN
  • Glucose Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
CHINA
  • Glucose Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
EUROPE
  • Glucose Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
FRANCE
  • Glucose Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
GERMANY
  • Glucose Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
ITALY
UNITED KINGDOM
  • Glucose Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
SPAINRUSSIAREST OF EUROPE
ASIA-PACIFIC
  • Glucose Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
AUSTRALIA
  • Glucose Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E)
INDIA
  • Glucose Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Glucose Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Glucose Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2023 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Glucose Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2023 (E)
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Diabetes Care, Inc.
  • ACON Laboratories, Inc.
  • AgaMatrix, Inc.
  • Alive Technologies Pty. Ltd.
  • ARKRAY, Inc.
  • Ascensia Diabetes Care Holdings AG
  • B. Braun Melsungen AG
  • Beurer GmbH
  • Dexcom, Inc.
  • GlySens Inc.
  • LifeScan, Inc.
  • Medtronic plc
  • Nova Biomedical Corporation
  • Omron Healthcare Co., Ltd.
  • Roche Diagnostics
  • Senseonics Holdings, Inc.
  • Terumo Corporation
  • Trividia Health, Inc.
  • Ypsomed Holding AG

Table Information